TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive Pooled Analysis of 12 Seperate Yervoy Studies Shows Survival-Curve Plateau at 3 Years October 25, 2013